Humanigen to Participate in H.C. Wainwright and Cantor Inves

Short Hills, New Jersey--(Newsfile Corp. - September 7, 2022) - Humanigen, Inc. (Nasdaq: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused on developing lenzilumab ("LENZ®"), a first-in

Related Keywords

New York , United States , Tim Morris , Jersey Newsfile Corp , Humanigen Inc , Nasdaq , Short Hills , Annual Global Investment , New York City , Addressing Challenges , Cell Therapy , Humanigen , Articipate , Wainwright , Cantor , Investor , Conferences , September , 022 ,